ONBI Stock Chart & Stats
$0.02
$0.00(0.00%)
At close: 4:00 PM EST
$0.02
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.02 - $0.02
Previous CloseN/A
Volume25.00K
Average Volume (3M)0.00
Market Cap
$4.18K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta20.50
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding8,369,763
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.00
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ONBI FAQ
What was ONE Bio Corp’s price range in the past 12 months?
ONE Bio Corp lowest stock price was $0.02 and its highest was $0.02 in the past 12 months.
What is ONE Bio Corp’s market cap?
ONE Bio Corp’s market cap is $4.18K.
When is ONE Bio Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ONE Bio Corp’s earnings last quarter?
Currently, no data Available
Is ONE Bio Corp overvalued?
According to Wall Street analysts ONE Bio Corp’s price is currently Overvalued.
Does ONE Bio Corp pay dividends?
ONE Bio Corp does not currently pay dividends.
What is ONE Bio Corp’s EPS estimate?
ONE Bio Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ONE Bio Corp have?
ONE Bio Corp has 8,369,763 shares outstanding.
What happened to ONE Bio Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ONE Bio Corp?
Currently, no hedge funds are holding shares in ONBI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ONE Bio Corp
ONE Bio Corp. functions as an agritech enterprise that, alongside its subsidiaries, employs eco-friendly manufacturing methods to develop and produce foundational chemicals, botanical extracts, health supplements, and organic goods. The company's operations are divided into two primary segments: Chemical and Herbal Extracts (CHE) and Organic Products (OP). The CHE division is dedicated to the creation, production, and market introduction of bio-ecological and non-prescription items. These products are formulated using compounds extracted from tobacco leaves and various other plant sources. Its offerings encompass chemical extracts such as Solanesol and Coenzyme Q10, in addition to herbal extracts like Resveratrol, 5-Hydroxytryptophan, and Ganoderma Tea, alongside granular and powdered fertilizers. Distribution for CHE products within China's bio-health and raw chemical intermediates sectors occurs through a network of independent third-party distributors, academic institutions, and hospital research facilities. Meanwhile, the OP unit manufactures a diverse array of health and energy beverages for both consumer and commercial use, organic food products, and fertilizers. These products, primarily bamboo-based, are marketed within the People's Republic of China. Its portfolio includes standard and vacuum-packed canned bamboo shoots, prepared mixed and seasoned vegetables, and the Japanese rice delicacy known as Kamameshi. This segment delivers its merchandise directly to supermarket chains, hotels, hospitals, and restaurants, augmented by sales through independent third-party distributors. Globally, ONE Bio Corp. exports its products to Japan, various Southeast Asian nations, European markets, and North America. Founded in 2000, the company was rebranded from ONE Holdings, Corp. to ONE Bio Corp. in November 2009 and is based in Aventura, Florida.
Technical Analysis
Aditxt
―
NewcelX
―
Dermata Therapeutics
―
Pasithea Therapeutics Corp
―
Virax Biolabs Group Ltd. Class A
―